Lyra Therapeutics Inc
NASDAQ:LYRA
Cash Flow Statement
Cash Flow Statement
Lyra Therapeutics Inc
Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||
Net Income |
(1)
|
(1)
|
(3)
|
(22)
|
(26)
|
(32)
|
(37)
|
(44)
|
(43)
|
(46)
|
(55)
|
(55)
|
(65)
|
(66)
|
(62)
|
(63)
|
(69)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
Stock-Based Compensation |
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
6
|
6
|
6
|
0
|
|
Other Non-Cash Items |
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
6
|
6
|
8
|
6
|
4
|
4
|
|
Change in Working Capital |
(0)
|
(5)
|
(3)
|
(1)
|
(1)
|
16
|
13
|
14
|
8
|
(0)
|
7
|
5
|
10
|
4
|
(1)
|
(5)
|
(5)
|
|
Cash from Operating Activities |
(1)
N/A
|
(5)
-444%
|
(5)
+1%
|
(21)
-289%
|
(25)
-17%
|
(14)
+44%
|
(20)
-47%
|
(26)
-27%
|
(30)
-17%
|
(42)
-39%
|
(43)
-1%
|
(43)
-2%
|
(47)
-9%
|
(53)
-12%
|
(56)
-6%
|
(63)
-12%
|
(70)
-10%
|
|
Investing Cash Flow | ||||||||||||||||||
Capital Expenditures |
0
|
0
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(65)
|
(59)
|
(60)
|
(75)
|
(12)
|
(7)
|
|
Cash from Investing Activities |
0
N/A
|
0
-25%
|
(1)
N/A
|
(2)
-230%
|
(3)
-65%
|
(3)
-19%
|
(3)
+2%
|
(3)
+1%
|
(2)
+32%
|
(2)
+26%
|
(1)
+28%
|
(65)
-5 185%
|
(60)
+8%
|
(60)
-1%
|
(75)
-25%
|
(13)
+83%
|
(10)
+20%
|
|
Financing Cash Flow | ||||||||||||||||||
Net Issuance of Common Stock |
30
|
90
|
90
|
90
|
60
|
1
|
1
|
1
|
0
|
101
|
101
|
101
|
100
|
50
|
50
|
69
|
78
|
|
Other |
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(0)
|
(0)
|
(0)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(4)
|
(4)
|
|
Cash from Financing Activities |
29
N/A
|
88
+200%
|
88
-1%
|
88
+0%
|
59
-33%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
-69%
|
96
+87 536%
|
96
0%
|
96
N/A
|
96
0%
|
47
-51%
|
47
0%
|
66
+40%
|
74
+13%
|
|
Change in Cash | ||||||||||||||||||
Net Change in Cash |
28
N/A
|
83
+191%
|
82
-1%
|
65
-21%
|
31
-52%
|
(18)
N/A
|
(23)
-34%
|
(29)
-23%
|
(32)
-12%
|
53
N/A
|
53
0%
|
(12)
N/A
|
(11)
+12%
|
(66)
-521%
|
(85)
-28%
|
(10)
+88%
|
(6)
+45%
|
|
Free Cash Flow | ||||||||||||||||||
Free Cash Flow |
(1)
N/A
|
(5)
-463%
|
(6)
-10%
|
(23)
-283%
|
(28)
-21%
|
(17)
+37%
|
(24)
-37%
|
(29)
-23%
|
(32)
-11%
|
(44)
-35%
|
(44)
0%
|
(44)
+0%
|
(47)
-9%
|
(53)
-12%
|
(57)
-6%
|
(64)
-13%
|
(73)
-14%
|